Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 161

Results For "ANDA"

2091 News Found

USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects
Drug Approval | March 30, 2022

USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects

Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint


Govt signs agreement with Sapigen Biologix to develop two vaccines
News | March 28, 2022

Govt signs agreement with Sapigen Biologix to develop two vaccines

Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project


Free guide to Colorectal Cancer Screening now available in Hindi
Healthcare | March 28, 2022

Free guide to Colorectal Cancer Screening now available in Hindi

Colorectal Cancer Screening is now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer


Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
News | March 28, 2022

Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr

Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments


NMPA approves Hansizhuang, its first monoclonal antibody
Drug Approval | March 27, 2022

NMPA approves Hansizhuang, its first monoclonal antibody

It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry


RCSE partner with Rela Hospitals for  advanced surgical course
Hospitals | March 26, 2022

RCSE partner with Rela Hospitals for advanced surgical course

These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training


Parata Systems earns HITRUST certification
News | March 25, 2022

Parata Systems earns HITRUST certification

It recognizes the company's commitment to safeguarding sensitive data, protecting patient information


Medtronic announces first patient implants for bladder incontinence
Medical Device | March 25, 2022

Medtronic announces first patient implants for bladder incontinence

Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy


CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma
News | March 25, 2022

CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma

Recommendation is based on pivotal data from the phase III POLARIX study


Japan approves BMS’ Breyanzi application for relapsed large B-cell lymphoma
Drug Approval | March 25, 2022

Japan approves BMS’ Breyanzi application for relapsed large B-cell lymphoma

This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan